222 related articles for article (PubMed ID: 36290845)
1. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
[No Abstract] [Full Text] [Related]
2. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.
Williams DM; Kim AH; Rogers O; Spivak JL; Moliterno AR
Exp Hematol; 2007 Nov; 35(11):1641-6. PubMed ID: 17920755
[TBL] [Abstract][Full Text] [Related]
3. Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children.
Ismael O; Shimada A; Hama A; Sakaguchi H; Doisaki S; Muramatsu H; Yoshida N; Ito M; Takahashi Y; Akita N; Sunami S; Ohtsuka Y; Asada Y; Fujisaki H; Kojima S
Pediatr Blood Cancer; 2012 Sep; 59(3):530-5. PubMed ID: 22106054
[TBL] [Abstract][Full Text] [Related]
4. Rapid progression of myelofibrosis in polycythemia vera patient carrying SRSF2 c.284C>A p.(Pro95His) and unique ASXL1 splice site c.1720-2A>G variant.
Kanduła Z; Kroll-Balcerzak R; Lewandowski K
J Clin Lab Anal; 2022 May; 36(5):e24388. PubMed ID: 35435261
[TBL] [Abstract][Full Text] [Related]
5. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
Tefferi A; Barbui T
Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718
[TBL] [Abstract][Full Text] [Related]
6. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
[TBL] [Abstract][Full Text] [Related]
8. Whole Exome Sequencing Reveals Novel Variants in Unexplained Erythrocytosis.
Khurana H; Muthusamy B; Yanamandra U; Garapati K; Premdeep H; Subramanian S; Pandey A
OMICS; 2023 Jul; 27(7):299-304. PubMed ID: 37428608
[TBL] [Abstract][Full Text] [Related]
9. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
[TBL] [Abstract][Full Text] [Related]
10. Detection of low allele burden of JAK2 exon 12 mutations using TA-cloning in patients with erythrocytosis.
Ohyashiki JH; Hisatomi H; Shimizu S; Sugaya M; Ohyashiki K
Jpn J Clin Oncol; 2009 Aug; 39(8):509-13. PubMed ID: 19491085
[TBL] [Abstract][Full Text] [Related]
11. Novel germline JAK2
Song J; Lanikova L; Kim SJ; Papadopoulos N; Meznarich J; Constantinescu SN; Parsegov B; Prchal JF; Prchal JT
Am J Hematol; 2024 Jul; 99(7):1220-1229. PubMed ID: 38629639
[TBL] [Abstract][Full Text] [Related]
12. [The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms].
Lyu XD; Li YW; Guo Z; Xin YP; Hu JY; Fan RH; Song YP
Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):35-39. PubMed ID: 31887834
[No Abstract] [Full Text] [Related]
13. Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.
Leszczynska A; Grzenkowicz-Wydra J; Chmielewska-Gorycka L; Bieniaszewska M; Hellmann A
Acta Haematol; 2016; 136(2):123-8. PubMed ID: 27410038
[TBL] [Abstract][Full Text] [Related]
14. Somatic JAK-2 V617F Mutational Analysis in Polycythemia Rubra Vera: a Tertiary Care Center Experience.
Sultan S; Irfan SM; Khan SR
Asian Pac J Cancer Prev; 2016; 17(3):1053-5. PubMed ID: 27039724
[TBL] [Abstract][Full Text] [Related]
15. Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review.
Chin-Yee B; Matyashin M; Cheong I; Bhai P; Lazo-Langner A; Almanaseer A; Kawata E; Levy MA; Stuart A; Lin H; Chin-Yee I; Sadikovic B; Hsia C
CMAJ Open; 2022; 10(4):E988-E992. PubMed ID: 36347562
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience.
Lee Y; Seo SH; Kim J; Kim SA; Lee JY; Lee JO; Bang SM; Park KU; Hwang SM
Mol Diagn Ther; 2024 May; 28(3):311-318. PubMed ID: 38568469
[TBL] [Abstract][Full Text] [Related]
17. ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.
Andréasson B; Pettersson H; Wasslavik C; Johansson P; Palmqvist L; Asp J
Br J Haematol; 2020 Jun; 189(5):913-919. PubMed ID: 32066200
[TBL] [Abstract][Full Text] [Related]
18. TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms.
Martínez-Avilés L; Besses C; Álvarez-Larrán A; Torres E; Serrano S; Bellosillo B
Ann Hematol; 2012 Apr; 91(4):533-41. PubMed ID: 21904853
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic erythrocytosis: a germline disease?
Elli EM; Mauri M; D'Aliberti D; Crespiatico I; Fontana D; Redaelli S; Pelucchi S; Spinelli S; Manghisi B; Cavalca F; Aroldi A; Ripamonti A; Ferrari S; Palamini S; Mottadelli F; Massimino L; Ramazzotti D; Cazzaniga G; Piperno A; Gambacorti-Passerini C; Piazza R
Clin Exp Med; 2024 Jan; 24(1):11. PubMed ID: 38244120
[TBL] [Abstract][Full Text] [Related]
20. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
Schnittger S; Bacher U; Haferlach C; Geer T; Müller P; Mittermüller J; Petrides P; Schlag R; Sandner R; Selbach J; Slawik HR; Tessen HW; Wehmeyer J; Kern W; Haferlach T
Haematologica; 2009 Mar; 94(3):414-8. PubMed ID: 19252176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
